PMDA — authorised 22 April 2009
- Marketing authorisation holder: GlaxoSmithKline K.K.
- Status: approved
🇯🇵 Arnuity Ellipta in Japan
PMDA authorised Arnuity Ellipta on 22 April 2009
Marketing authorisation
Arnuity Ellipta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Japan
Frequently asked questions
Is Arnuity Ellipta approved in Japan?
Yes. PMDA authorised it on 22 April 2009.
Who is the marketing authorisation holder for Arnuity Ellipta in Japan?
GlaxoSmithKline K.K. holds the Japanese marketing authorisation.